abstract |
The invention describes a novel combination of neutraceuticals. The invention also provides novel kits comprising a novel combination of neutraceuticals. The invention also provides methods for treating symptoms or delaying the progression of neuropathy, e.g., diabetic neuropathy, ischemic neuropathy, metabolic neuropathy, neuropathy due to aging, HIV neuropathy, chemotherapeutic-induced neuropathy, para-neoplastic neuropathy, metabolic neuropathy, and the like. |